ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ICU MEDICAL INC/DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$161.24−1.75 (-1.07%)
Close on Oct 19, 2026
- Market cap
- $4.04B
- P/E (TTM)
- 134.4
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
26M of 25M shares
Institutional holders
288
47 new, 30 sold out
Net institutional buying
4M
In Q2 2026
Insider trades, 12 months
0 buys · 19 sales
Net sold $8.27M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 3,649,469 | – | 13G (passive) amendment | Sep 30, 2024 |
| JANUS HENDERSON GROUP Ltd. | 2,781,621 | 11.10% | 13G (passive) amendment | Jun 30, 2026 |
| Janus Henderson Group PLC | 2,470,146 | 10.00% | 13G (passive) amendment | Jun 30, 2025 |
| Vanguard Portfolio Management | 1,455,765 | 5.82% | 13G (passive) | Mar 31, 2026 |
| Vanguard Capital Management | 1,298,459 | 5.19% | 13G (passive) | Mar 31, 2026 |
| Fuller & Thaler Asset Management, Inc. | 1,298,127 | 5.19% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ICUI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3,753,409 | 15.01% | $550.25M | +145,087 | 0.01% |
| Jupiter Topco LLC | 2,781,620 | 11.12% | $407.79M | New | 0.17% |
| Vanguard Portfolio Management LLC | 1,470,583 | 5.88% | $215.59M | +32,907 | 0.01% |
| Fuller & Thaler Asset Management, Inc. | 1,298,127 | 5.19% | $190.31M | +77,588 | 0.52% |
| Vanguard Capital Management LLC | 1,123,237 | 4.49% | $164.67M | +11,362 | 0.00% |
| Dimensional Fund Advisors LP | 1,053,476 | 4.21% | $154.44M | +69,674 | 0.03% |
| State Street Corp | 1,024,369 | 4.10% | $150.18M | +56,316 | 0.00% |
| Schroder Investment Management Group | 739,138 | 2.96% | $109.34M | +37,858 | 0.08% |
| Ameriprise Financial Inc | 689,573 | 2.76% | $101.09M | +83,845 | 0.02% |
| Geode Capital Management, LLC | 660,423 | 2.64% | $96.84M | +49,204 | 0.01% |
| River Road Asset Management, LLC | 626,290 | 2.50% | $91.81M | −20,140 | 1.02% |
| Citadel Advisors LLC | 536,225 | 2.14% | $78.61M | +202,889 | 0.01% |
| Neuberger Berman Group LLC | 451,279 | 1.80% | $66.16M | +4,860 | 0.04% |
| JPMorgan Chase & Co | 440,468 | 1.76% | $65.31M | −27,349 | 0.00% |
| Goldman Sachs Group Inc | 417,342 | 1.67% | $61.18M | +94,651 | 0.01% |
| Thrivent Financial for Lutherans | 381,139 | 1.52% | $55.88K | −52,360 | 0.09% |
| Morgan Stanley | 372,583 | 1.49% | $54.62M | −154,259 | 0.00% |
| Bank Of America Corp /De/ | 368,754 | 1.47% | $54.06M | +37,015 | 0.00% |
| Toronto Dominion Bank | 358,023 | 1.43% | $52.49M | +149,091 | 0.06% |
| Charles Schwab Investment Management Inc | 331,052 | 1.32% | $48.53M | +8,573 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 288 | 26M | 100.0% | 47 / 120 | 83 / 30 | 5M | 1M |
| Q1 2026 | 276 | 25M | 100.0% | 37 / 92 | 102 / 47 | 4M | 3M |
| Q4 2025 | 292 | 27M | 100.0% | 59 / 97 | 97 / 30 | 4M | 4M |
| Q3 2025 | 270 | 26M | 100.0% | 49 / 89 | 95 / 48 | 3M | 2M |
| Q2 2025 | 271 | 25M | 100.0% | 34 / 124 | 80 / 42 | 2M | 1M |
| Q1 2025 | 281 | 25M | 98.0% | 39 / 86 | 106 / 38 | 2M | 2M |
| Q4 2024 | 286 | 24M | 96.8% | 41 / 103 | 96 / 40 | 2M | 3M |
| Q3 2024 | 289 | 25M | 100.0% | 57 / 107 | 77 / 21 | 6M | 2M |
| Q2 2024 | 255 | 25M | 98.2% | 43 / 99 | 75 / 38 | 3M | 3M |
| Q1 2024 | 252 | 25M | 99.0% | 38 / 102 | 71 / 27 | 3M | 2M |
| Q4 2023 | 241 | 23M | 91.7% | 56 / 90 | 62 / 31 | 6M | 5M |
| Q3 2023 | 220 | 22M | 89.2% | 30 / 72 | 80 / 40 | 2M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ICUI | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 1,505,864 | 6.02% | $220.76M | 0.20% | Jun 30, 2026 |
| Janus Henderson Enterprise Fund | 1,230,753 | 4.92% | $180.43M | 0.81% | Jun 30, 2026 |
| Undiscovered Managers Behavioral Value Fund | 1,054,324 | 4.22% | $154.56M | 1.71% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 791,929 | 3.17% | $116.10M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 634,293 | 2.54% | $92.99M | 0.11% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 573,522 | 2.29% | $84.08M | 0.04% | Jun 30, 2026 |
| Columbia Small Cap Growth Fund | 448,705 | 1.79% | $60.75M | 1.65% | May 31, 2026 |
| Janus Henderson Triton Fund | 374,990 | 1.50% | $54.97M | 0.93% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 363,100 | 1.45% | $53.23M | 0.08% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 286,086 | 1.14% | $41.94M | 0.04% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 270,008 | 1.08% | $45.50M | 0.13% | Jul 31, 2026 |
| Thrivent Small Cap Stock Fund | 257,476 | 1.03% | $43.39M | 1.49% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 231,353 | 0.93% | $33.92M | 0.23% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 230,029 | 0.92% | $33.72M | 0.20% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 227,281 | 0.91% | $38.30M | 0.20% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Vivek Jain | Chairman and CEO, Director | 276,993 | 1.11% | Mar 16, 2026 |
| Virginia Ruth Sanzone | VP, General Counsel | 16,020 | 0.06% | Sep 3, 2026 |
| Brian Michael Bonnell | Chief Financial Officer | 56,062 | 0.22% | Sep 1, 2026 |
| Daniel Woolson | VP, GM-Infusion Capital | 17,062 | 0.07% | Aug 13, 2026 |
| Ben Sousa | Chief Information Officer | 3,076 | 0.01% | Aug 12, 2026 |
| Christian B. Voigtlander | Chief Operating Officer | 37,377 | 0.15% | Aug 11, 2026 |
| Elisha W. Finney | Director | 4,871 | 0.02% | Aug 11, 2026 |
| David F. Hoffmeister | Director | 6,004 | 0.02% | May 13, 2026 |
| David C. Greenberg | Director | 9,714 | 0.04% | May 13, 2026 |
| Donald Abbey | Director | 6,004 | 0.02% | May 13, 2026 |
| Laurie Hernandez | Director | 4,862 | 0.02% | May 13, 2026 |
| Kolleen T. Kennedy | Director | 4,539 | 0.02% | May 13, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Virginia Ruth Sanzone VP, General Counsel | Sep 3, 2026 | Sale(10b5-1 plan) | −1,238 | $168.44 | $208.53K | 16,020 |
| Virginia Ruth Sanzone VP, General Counsel | Sep 3, 2026 | Sale(10b5-1 plan) | −724 | $169.53 | $122.74K | 15,296 |
| Virginia Ruth Sanzone VP, General Counsel | Sep 3, 2026 | Sale(10b5-1 plan) | −692 | $171.52 | $118.69K | 14,604 |
| Virginia Ruth Sanzone VP, General Counsel | Sep 3, 2026 | Sale(10b5-1 plan) | −2,202 | $167.67 | $369.21K | 17,258 |
| Brian Michael Bonnell Chief Financial Officer | Sep 1, 2026 | Sale(10b5-1 plan) | −6,381 | $175.00 | $1.12M | 56,062 |
| Brian Michael Bonnell Chief Financial Officer | Aug 31, 2026 | Sale(10b5-1 plan) | −4,568 | $173.44 | $792.27K | 63,556 |
| Brian Michael Bonnell Chief Financial Officer | Aug 31, 2026 | Sale(10b5-1 plan) | −1,712 | $171.05 | $292.84K | 70,038 |
| Brian Michael Bonnell Chief Financial Officer | Aug 31, 2026 | Sale(10b5-1 plan) | −1,914 | $172.12 | $329.44K | 68,124 |
| Brian Michael Bonnell Chief Financial Officer | Aug 31, 2026 | Sale(10b5-1 plan) | −1,113 | $173.91 | $193.56K | 62,443 |
| Daniel Woolson VP, GM-Infusion Capital | Aug 13, 2026 | Sale | −5,417 | $181.33 | $982.26K | 17,062 |
| Ben Sousa Chief Information Officer | Aug 12, 2026 | Sale | −2,250 | $178.32 | $401.22K | 3,076 |
| Christian B. Voigtlander Chief Operating Officer | Aug 11, 2026 | Sale | −8,929 | $182.93 | $1.63M | 37,377 |
| Elisha W. Finney Director | Aug 11, 2026 | Sale | −378 | $182.48 | $68.98K | 4,871 |
| Daniel Woolson President | May 22, 2026 | Sale | −2,123 | $132.21 | $280.68K | 22,479 |
| Virginia Ruth Sanzone VP, General Counsel | May 14, 2026 | Sale | −2,447 | $124.08 | $303.62K | 19,460 |
| Donald Abbey Director | May 13, 2026 | Option exercise | +1,254 | – | – | 6,004 |
| Elisha W. Finney Director | May 13, 2026 | Option exercise | +1,254 | – | – | 5,249 |
| David F. Hoffmeister Director | May 13, 2026 | Option exercise | +1,254 | – | – | 6,004 |
| Laurie Hernandez Director | May 13, 2026 | Option exercise | +1,254 | – | – | 4,862 |
| Kolleen T. Kennedy Director | May 13, 2026 | Option exercise | +1,254 | – | – | 4,539 |
| David C. Greenberg Director | May 13, 2026 | Option exercise | +1,254 | – | – | 9,214 |
| David C. Greenberg Director | May 12, 2026 | Sale | −2,424 | $122.91 | $297.93K | 7,960 |
| David C. Greenberg Director | May 12, 2026 | Option exercise | +2,424 | $101.06 | $244.97K | 10,384 |
| Donald Abbey Director | Mar 25, 2026 | Other | −704 | – | – | 4,046 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 15, 2026 | Option exercise | +5,700 | – | – | 24,330 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 15, 2026 | Tax withholding | −3,150 | $125.85 | $396.43K | 21,180 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 15, 2026 | Option exercise | +1,624 | – | – | 22,804 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 15, 2026 | Tax withholding | −897 | $125.85 | $112.89K | 21,907 |
| Vivek Jain Chairman and CEO, Director | Mar 15, 2026 | Tax withholding | −9,452 | $125.85 | $1.19M | 124,654 |
| Vivek Jain Chairman and CEO, Director | Mar 15, 2026 | Option exercise | +4,872 | – | – | 129,526 |
| Vivek Jain Chairman and CEO, Director | Mar 15, 2026 | Tax withholding | −2,693 | $125.85 | $338.91K | 126,833 |
| Vivek Jain Chairman and CEO, Director | Mar 15, 2026 | Option exercise | +17,100 | – | – | 134,106 |
| Brian Michael Bonnell Chief Financial Officer | Mar 15, 2026 | Tax withholding | −1,795 | $125.85 | $225.90K | 71,750 |
| Brian Michael Bonnell Chief Financial Officer | Mar 15, 2026 | Option exercise | +11,400 | – | – | 76,097 |
| Brian Michael Bonnell Chief Financial Officer | Mar 15, 2026 | Tax withholding | −5,800 | $125.85 | $729.93K | 70,297 |
| Brian Michael Bonnell Chief Financial Officer | Mar 15, 2026 | Option exercise | +3,248 | – | – | 73,545 |
| Christian B. Voigtlander Chief Operating Officer | Mar 15, 2026 | Option exercise | +11,400 | – | – | 51,154 |
| Christian B. Voigtlander Chief Operating Officer | Mar 15, 2026 | Option exercise | +3,248 | – | – | 48,101 |
| Christian B. Voigtlander Chief Operating Officer | Mar 15, 2026 | Tax withholding | −6,301 | $125.85 | $792.98K | 44,853 |
| Christian B. Voigtlander Chief Operating Officer | Mar 15, 2026 | Tax withholding | −1,795 | $125.85 | $225.90K | 46,306 |
| Ben Sousa Chief Information Officer | Mar 15, 2026 | Tax withholding | −718 | $125.85 | $90.36K | 5,326 |
| Ben Sousa Chief Information Officer | Mar 15, 2026 | Option exercise | +1,300 | – | – | 6,044 |
| Daniel Woolson VP, GM-Infusion Capital | Mar 15, 2026 | Tax withholding | −1,295 | $125.85 | $162.98K | 24,602 |
| Daniel Woolson VP, GM-Infusion Capital | Mar 15, 2026 | Option exercise | +2,924 | – | – | 25,897 |
| Brian Michael Bonnell Chief Financial Officer | Mar 8, 2026 | Option exercise | +71,757 | – | – | 104,364 |
| Brian Michael Bonnell Chief Financial Officer | Mar 8, 2026 | Tax withholding | −39,667 | $132.00 | $5.24M | 64,697 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 8, 2026 | Option exercise | +23,917 | – | – | 30,424 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 8, 2026 | Tax withholding | −13,221 | $132.00 | $1.75M | 17,203 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 8, 2026 | Tax withholding | −1,762 | $132.00 | $232.58K | 18,630 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 8, 2026 | Option exercise | +3,189 | – | – | 20,392 |
| Ben Sousa Chief Information Officer | Mar 8, 2026 | Tax withholding | −529 | $132.00 | $69.83K | 4,744 |
| Ben Sousa Chief Information Officer | Mar 8, 2026 | Option exercise | +957 | – | – | 5,273 |
| Ben Sousa Chief Information Officer | Mar 8, 2026 | Tax withholding | −3,967 | $132.00 | $523.64K | 4,316 |
| Ben Sousa Chief Information Officer | Mar 8, 2026 | Option exercise | +7,177 | – | – | 8,283 |
| Daniel Woolson VP, GM-Infusion Capital | Mar 8, 2026 | Tax withholding | −6,877 | $132.00 | $907.76K | 21,450 |
| Daniel Woolson VP, GM-Infusion Capital | Mar 8, 2026 | Option exercise | +16,147 | – | – | 28,327 |
| Daniel Woolson VP, GM-Infusion Capital | Mar 8, 2026 | Option exercise | +2,153 | – | – | 23,603 |
| Daniel Woolson VP, GM-Infusion Capital | Mar 8, 2026 | Tax withholding | −630 | $132.00 | $83.16K | 22,973 |
| Vivek Jain Chairman and CEO, Director | Mar 8, 2026 | Tax withholding | −59,500 | $132.00 | $7.85M | 117,006 |
| Vivek Jain Chairman and CEO, Director | Mar 8, 2026 | Option exercise | +107,635 | – | – | 176,506 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Sanzone Virginia Officer | Sep 3, 2026 | 4,856 | $819.15K | Sep 3, 2026 | Performance and Restricted Stock |
| Bonnell Brian Officer | Sep 1, 2026 | 6,381 | $1.12M | Sep 1, 2026 | Restricted Stock |
| Bonnell Brian Officer | Aug 31, 2026 | 9,307 | $1.61M | Aug 31, 2026 | Performance Shares and Restricted Stock |
| Woolson Daniel Officer | Aug 13, 2026 | 5,417 | $982.26K | Aug 13, 2026 | Performance Stock Units |
| Sousa Benjamin Officer | Aug 12, 2026 | 2,250 | $401.21K | Aug 12, 2026 | Restricted Stock Vesting Under a Registered Plan |
| W. Finney Elisha Director | Aug 11, 2026 | 378 | $68.98K | Aug 11, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Voigtlander Christian Officer | Aug 11, 2026 | 8,929 | $1.63M | Aug 11, 2026 | Previously Exercised Options |
| Woolson Daniel Officer | May 22, 2026 | 2,123 | $280.68K | May 22, 2026 | Performance Stock Units |
| Sanzone Virginia Officer | May 14, 2026 | 2,447 | $303.62K | May 14, 2026 | Performance Stock Units |
| C. Greenberg David Director | May 12, 2026 | 2,424 | $297.93K | May 12, 2026 | Exercise of options under a registered plan |
| Woolson Daniel Officer | Nov 25, 2025 | 2,897 | $441.36K | Nov 25, 2025 | Performance Shares |
| W. Finney Elisha Director | Nov 12, 2025 | 1,285 | $180.44K | Nov 11, 2025 | Stock Option Exercise |
| Sanzone Virginia Officer | Nov 12, 2025 | 930 | $132.38K | Nov 11, 2025 | Restricted Stock |
| Sanzone Virginia Officer | May 30, 2025 | 700 | $93.54K | May 30, 2025 | Performance Shares |
| Elisha W. Finney Director | May 19, 2025 | 600 | $83.35K | May 19, 2025 | RESTRICTED STOCK |